SCHEMBL2882567

SCHEMBL2882567

CC(=O)Nc1cccc(-c2cccc(-c3cc4ccnn4c(S(C)(=O)=O)n3)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.47
PIP4K2A P48426 1/20 0.46
PIP4K2B P78356 1/20 0.46
RXFP1 Q9HBX9 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
FYN P06241 6/20 0.44
NPC1 O15118 5/20 0.44
RAB9A P51151 4/20 0.44
TP53 P04637 2/20 0.44
STAT1 P42224 1/20 0.44
MAPT P10636 2/20 0.42
PLK1 P53350 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BRAF P15056 1/20 0.42
POLB P06746 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP17A1 P05093 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2882272 0.95 FYN (0.48) RAD52PIP4K2APIP4K2BRXFP1SMN1; SMN2
SCHEMBL2214072 0.93 FYN (0.50) RAD52SMN1; SMN2ALDH1A1KDM4EFYN
SCHEMBL2211969 0.90 FYN (0.44) RAD52PIP4K2APIP4K2BRXFP1SMN1; SMN2
SCHEMBL2209540 0.83 BPTF (0.36) SMN1; SMN2ALDH1A1KDM4ERAB9ATP53
SCHEMBL2880093 0.82 RAD52 (0.48) RAD52RXFP1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2213858 0.78 CDK2 (0.42) RXFP1SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL2882015 0.77 CYP17A1 (0.47) RAD52RXFP1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2882294 0.76 FYN (0.48) PIP4K2APIP4K2BRXFP1SMN1; SMN2ALDH1A1
SCHEMBL2214081 0.76 SCD (0.42) SMN1; SMN2ALDH1A1KDM4ERAB9ATP53
SCHEMBL2319146 0.76 FYN (0.51) RAD52SMN1; SMN2ALDH1A1KDM4EFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745446-B2 Pyrazolo[1,5-c]pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-29 US disclosed
US-20070254046-A1 Novel Pyrazolopyrimidines ALTANA PHARMA AG (DE) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254046-A1 Novel Pyrazolopyrimidines MCL1, RARS2, CDK4 RAD52 508/4885PIP4K2A 1325/4885PIP4K2B 1081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.